Lipopolysaccharide can trigger a cathepsin B-dependent programmed death response in human endothelial cells

Jie H Li1, Alessio D'Alessio, Jordan S Pober

  • 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520-8089, USA.

Summary

Lipopolysaccharide (LPS) triggers programmed cell death in human endothelial cells. This death can be caspase- or cathepsin B-dependent, influenced by various signaling pathways and inhibitors.